Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: Results of a randomized phase III study

Annals of Oncology

Volumn 27, Issue 5, 2016, Pages 834-842

  Bujko, K ^a   Wyrwicz, L ^b   Rutkowski, A ^b   Malinowska, M ^c   Pietrzak, L ^a   Krynski J ^b   Michalski, W ^d   Oledzki, J ^e   Kusnierz J ^d   Zajac, L ^b   Bednarczyk, M ^b   Szczepkowski, M ^f,g   Tarnowski, W ^h   Kosakowska, E ^b   Zwolinski J ^b   Winiarek, M ^b   Wisniowska K ^a   Partycki, M ^a   Beczkowska, K ^a   Polkowski, W ⁱ   Stylinski R ⁱ   Wierzbicki, R ^j   Bury, P ⁱ   Jankiewicz, M ^i,k   Paprota, K ^k   Lewicka, M ⁱ   Cisel B ⁱ   Skorzewska M ⁱ   Mielko, J ⁱ   Bebenek, M ^l   Maciejczyk, A ^m   Kapturkiewicz, B ^l   Dybko, A ⁿ   Hajac, L ⁿ   Wojnar, A ^o   Lesniak T ^p   Zygulska, J ^p   Jantner, D ^p   Chudyba, E ^p   Zegarski, W ^q   Las Jankowska, M ^q   Jankowski, M ^q   Kolodziejski L ^r   Radkowski, A ^s   Zelazowska Omiotek, U ^s   Czeremszynska B ^t   Kepka, L ^t   Kolb Sielecki, J ^t   Toczko, Z ^u   Fedorowicz, Z ^u   Dziki, A ^v   Danek, A ^a   Nawrocki, G ^d   Sopylo R ^d   Markiewicz, W ^w   Kedzierawski, P ^x   Wydmanski J ^y   Albinski, J ^z   Banas R ^z   Chmielowska, E ^z   Bal, W ^z   Baszczyk Mnich, J ^z   Bialas, M ^z   Borowiec, T ^z   Bujko, M ^z   Cencelewicz, A ^z   Chomik, K ^z   Chwalinski, M ^z   Ciepela, I ^z   Dupla, D ^z   Florek, A ^z   Gornicki A ^z   Jeziorski, K ^z   Jozwickil W ^z   Kobiela, J ^z   Koda, M ^z   Kolodziej, P ^z   Kruszewski, P ^z   Kryj, M ^z   Kuciel Lisiecka, G ^z   Kwiatkowski, R ^z   Lachowski, A ^z   Liszka Dalecki, P ^z   Majewski, A ^z   Majewski, W ^z   Majsak, T ^z   Maka, D ^z   Malka, M ^z   Mazurkiewicz, A ^z   Morawiec, J ^z   Nogal, E ^z   Olejniczak, M ^z   Olkowski, D ^z   Ostrowska Cichocka, K ^z   Pietruszka, M ^z   Piotrkowski, G ^z   Plewicka, M ^z   Porzuczek Zuziak, D ^z   Reszke, J ^z   Rychter, A ^z   Sadowski, J ^z   Salata, A ^z   Serkies, K ^z   Srutek, E ^z   Szostak B ^z   Tuziak, T ^z   Tyralik, D ^z   Skoczylas, J ^z   Wachua, E ^z   Wandzel, P ^z   Winkler Spytkowska, B ^z   Wojtasik, P ^z   Wronski, K ^z   Zemal, M ^z   Zygulski, I ^z   more..

^a Departments of Radiotherapy   (Poland)

^b Departments of Gastroenterological Oncology   (Poland)

^c Departments of Cardiovascular Pathology   (Poland)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

^g BIELANSKI HOSPITAL   (Poland)

^h Orlowski Hospital Warsaw   (Poland)

ⁱ MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^j MSW Hospital   (Poland)

^k ST JOHN S CANCER CENTER   (Poland)

^l 2nd Dept of Gen and Oncol Surg   (Poland)

^m Departments of Radiotherapy   (Poland)

ⁿ Departments of Medical Oncology   (Poland)

^o Silesian Oncological Centre   (Poland)

^p Centre of Oncology   (Poland)

^q NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^r Departments of Surgery   (Poland)

^s Regional Cancer Centre   (Poland)

^t Radiotherapy Department   (Poland)

^u Regional Hospital   (Poland)

^v MEDICAL UNIVERSITY OF LODZ   (Poland)

^w Regional Cancer Center   (Poland)

^x Regional Oncology Center   (Poland)

^y INSTITUTE OF ONCOLOGY   (Poland)

^z NONE

more..

Author keywords

Preoperative chemoradiation; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; SURVIVAL RATE; TREATMENT OUTCOME; CANCER STAGING; CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR;

AGED; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; CONSOLIDATION CHEMOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS;

EID: 84964770531     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw062     Document Type: Article

References (24)

1. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-3694.
2. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Long-term results of randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.
3. Ngan SY, Burmeister B, Fisher RJ et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012; 30: 3827-3833.
4. Pettersson D, Lörinc E, Holm T et al. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg 2015; 102: 972-978.
5. Radu C, Berglund A, Pahlman L, Glimelius B. Short course preoperative radiotherapy with delayed surgery in rectal cancer-a retrospective study. Radiother Oncol 2008; 87: 343-349.
6. Widder J, Herbst F, Scheithauer W. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer. Acta Oncol 2005; 44: 921-923.
7. Martijnse IS, Dudink RL, Kusters M et al. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen. Ann Surg Oncol 2012; 19: 392-401.
8. Bujko K, Nasierowska-Guttmejer A, Wyrwicz L et al. Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol 2013; 107: 171-177.
9. Aschele C, Cionini L, Lonardi S et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011; 29: 2773-2780.
10. Gérard JP, Azria D, Gourgou-Bourgade S et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 2012; 30: 4558-4565.
11. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-9264.
12. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
13. Napolitano M, D'Alterio C, Cardone E et al. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Oncotarget 2015; 6: 8261-8270.
14. O'Connell MJ, Martenson JA, Wieand HS et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-507.
15. Smalley SR, Benedetti JK, Williamson SK et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24: 3542-3547.
16. Rödel C, Graeven U, Fietkau R et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2015; 16: 979-989.
17. Schmoll H, Haustermans K, Price T et al. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis. J Clin Oncol 2014; 32(5s; suppl): abstr 3501.
18. Allegra CJ, Yothers G, O'Connell MJ et al. Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase iii randomized clinical trial. J Natl Cancer Inst 2015; 107(11): djv248.
19. Tyc-Szczepaniak D, Wyrwicz L, Kepka et al. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study. Ann Oncol 2013; 24: 2829-2834.
20. van Dijk TH, Tamas K, Beukema JC et al. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol 2013; 24: 1762-1769.
21. Myerson RJ, Tan B, Hunt S et al. Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys 2014; 88: 829-836.
22. Youssef FF, Markovina S, Khwaja SS et al. Matched pair analysis of sequential short course radiation therapy and FOLFOX chemotherapy as preoperative therapy for rectal cancer: improved DFS compared to institutional controls favors near total neoadjuvant therapy. Int J Radiat Oncol Biol Phys 2015; 93: suppl S125.
23. Shin SJ, Yoon HI, Kim NK et al. Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol 2011; 6: 99-106.
24. Nilsson PJ, van Etten B, Hospers GA et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-the RAPIDO trial. BMC Cancer 2013; 13: 279.